State Of Alaska, Department Of Revenue Repligen Corp Transaction History

State Of Alaska, Department Of Revenue

  • $9.79 Billion
  • Q3 2025

A detailed history of State Of Alaska, Department Of Revenue transactions in Repligen Corp stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 5,599 shares of RGEN stock, worth $809,447. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,599
Previous 5,864 4.52%
Holding current value
$809,447
Previous $729,000 2.61%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025
SELL
$111.43 - $134.0 $29,528 - $35,510
-265 Reduced 4.52%
5,599 $748,000
Q2 2025

Jul 16, 2025
SELL
$108.89 - $145.23 $26,133 - $34,855
-240 Reduced 3.93%
5,864 $729,000
Q1 2025

Apr 21, 2025
BUY
$127.24 - $174.24 $20,994 - $28,749
165 Added 2.78%
6,104 $776,000
Q4 2024

Jan 27, 2025
SELL
$123.41 - $160.92 $12,958 - $16,896
-105 Reduced 1.74%
5,939 $854,000
Q3 2024

Oct 24, 2024
BUY
$119.79 - $167.35 $49,113 - $68,613
410 Added 7.28%
6,044 $899,000
Q1 2024

Apr 19, 2024
BUY
$170.78 - $208.42 $4,269 - $5,210
25 Added 0.45%
5,634 $1.04 Million
Q4 2023

Jan 19, 2024
SELL
$114.17 - $185.35 $63,364 - $102,869
-555 Reduced 9.0%
5,609 $1.01 Million
Q3 2023

Oct 16, 2023
SELL
$138.78 - $176.51 $35,388 - $45,010
-255 Reduced 3.97%
6,164 $980,000
Q2 2023

Jul 24, 2023
SELL
$138.42 - $180.31 $96,478 - $125,676
-697 Reduced 9.79%
6,419 $908,000
Q1 2023

Apr 17, 2023
SELL
$154.26 - $198.1 $16,968 - $21,791
-110 Reduced 1.52%
7,116 $1.2 Million
Q4 2022

Jan 11, 2023
BUY
$162.42 - $220.56 $10,557 - $14,336
65 Added 0.91%
7,226 $1.22 Million
Q3 2022

Oct 20, 2022
SELL
$160.42 - $256.21 $36,094 - $57,647
-225 Reduced 3.05%
7,161 $1.34 Million
Q2 2022

Jul 08, 2022
BUY
$140.68 - $188.02 $21,102 - $28,203
150 Added 2.07%
7,386 $1.2 Million
Q1 2022

Apr 14, 2022
SELL
$161.19 - $257.96 $33,849 - $54,171
-210 Reduced 2.82%
7,236 $1.36 Million
Q4 2021

Jan 12, 2022
SELL
$247.59 - $304.47 $100,273 - $123,310
-405 Reduced 5.16%
7,446 $1.97 Million
Q3 2021

Oct 07, 2021
SELL
$194.77 - $324.21 $15,192 - $25,288
-78 Reduced 0.98%
7,851 $2.27 Million
Q2 2021

Jul 12, 2021
SELL
$165.87 - $220.95 $130,539 - $173,887
-787 Reduced 9.03%
7,929 $1.58 Million
Q1 2021

Apr 09, 2021
BUY
$180.37 - $226.26 $97,039 - $121,727
538 Added 6.58%
8,716 $1.69 Million
Q4 2020

Jan 08, 2021
SELL
$148.08 - $206.57 $22,656 - $31,605
-153 Reduced 1.84%
8,178 $1.57 Million
Q3 2020

Oct 05, 2020
SELL
$122.51 - $158.27 $4,900 - $6,330
-40 Reduced 0.48%
8,331 $1.23 Million
Q2 2020

Jul 06, 2020
BUY
$94.33 - $140.48 $29,619 - $44,110
314 Added 3.9%
8,371 $1.03 Million
Q1 2020

Apr 06, 2020
BUY
$84.96 - $109.14 $30,330 - $38,962
357 Added 4.64%
8,057 $777,000
Q4 2019

Jan 07, 2020
SELL
$73.84 - $93.08 $40,612 - $51,194
-550 Reduced 6.67%
7,700 $712,000
Q3 2019

Oct 02, 2019
SELL
$76.65 - $95.51 $464,345 - $578,599
-6,058 Reduced 42.34%
8,250 $632,000
Q2 2019

Jul 23, 2019
BUY
$54.2 - $85.95 $61,354 - $97,295
1,132 Added 8.59%
14,308 $1.23 Million
Q1 2019

Apr 09, 2019
BUY
$49.45 - $62.8 $5,439 - $6,908
110 Added 0.84%
13,176 $778,000
Q4 2018

Jan 10, 2019
BUY
$48.26 - $68.88 $4,584 - $6,543
95 Added 0.73%
13,066 $689,000
Q3 2018

Oct 09, 2018
BUY
$46.8 - $58.97 $31,917 - $40,217
682 Added 5.55%
12,971 $719,000
Q2 2018

Jul 10, 2018
BUY
$35.26 - $47.04 $6,699 - $8,937
190 Added 1.57%
12,289 $578,000
Q1 2018

Apr 19, 2018
BUY
$30.92 - $37.27 $144,087 - $173,678
4,660 Added 62.64%
12,099 $437,000
Q4 2017

Jan 19, 2018
BUY
$32.53 - $38.92 $3,903 - $4,670
120 Added 1.64%
7,439 $269,000
Q3 2017

Oct 16, 2017
BUY
$36.98 - $46.06 $270,656 - $337,113
7,319
7,319 $280,000

Others Institutions Holding RGEN

# of Institutions
510
Shares Held
59M
Call Options Held
89.3K
Put Options Held
679K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email